Literature DB >> 31418815

Effects of comorbidity on Tourette's tic severity and quality of life.

Hilde M Huisman-van Dijk1,2, Suzy J M A Matthijssen1,2, Ruben T S Stockmann1, Anne V Fritz1, Danielle C Cath3,4,5.   

Abstract

OBJECTIVE: The aim of this study is to gain more insight in the differential contributions of anxiety, depression and obsessive-compulsive (OC) symptom severity to quality of life (QoL) and tic severity in adults with Tourette Disorder (TD).
METHODS: Self-reported OC symptom, anxiety and depression severity measures were used to investigate their predictive value on QoL and Tic severity in adult TD patients (N = 187), using correlation, regression, and mediation analyses.
RESULTS: Tic severity has no effect on QoL. Depression severity directly reduces QoL, whereas anxiety and OC symptom severity have an indirect effect on QoL, mediated by depression severity. OC symptom severity directly affects tic severity, whereas depression and anxiety severity do not have a direct effect on tic or OC severity. Finally, anxiety severity indirectly impacts tic severity, with OC symptom severity functioning as a mediator.
CONCLUSION: In line with and extending previous studies, these findings indicate that OC symptom severity directly influences tic symptom severity whereas depression severity directly influences QoL in TD. Results imply that to improve QoL in TD patients, treatment should primarily focus on diminishing OC and depressive symptom severity rather than focusing on tic reduction.
© 2019 The Authors. Acta Neurologica Scandinavica published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Tourette syndrome; comorbidity; depression; obsessive-compulsive disorder; quality of life

Mesh:

Year:  2019        PMID: 31418815      PMCID: PMC6899939          DOI: 10.1111/ane.13155

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


INTRODUCTION

Tourette's Disorder (TD) is a chronic neuropsychiatric disorder with childhood onset, characterized by multiple motor and one or more vocal (phonic) tics lasting longer than a year, with no tic‐free period of more than three consecutive months.1 Up to approximately 90% of adult TD patients suffer from comorbid disorders, with obsessive‐compulsive disorder (OCD; 20%‐60%), attention deficit and hyperactivity disorder (ADHD; 21%‐90%), depression (18%‐30%) and anxiety disorders (18%) being the most frequent comorbidities occurring in TD.2, 3, 4, 5, 6, 7, 8, 9 In addition, mood, anxiety, and substance abuse disorders are found to be more prevalent among participants with TD and comorbid OCD compared with TD patients without OCD comorbidity.5, 6, 7, 9 The interrelationships between the various comorbidities in TD seem unclear, as well as the differential contributions of these comorbidities to tic severity and Quality of Life (QoL). This study focusses on the relationships between obsessive‐compulsive (OC), anxiety and depressive symptom severity on the one hand, and tic symptom severity and QoL on the other. Although the neurobiological relationship between tics and OC symptoms is widely established,10 the extent at which OC symptom severity contributes to tic severity within TD patients is not fully clarified. Some studies indicate no association between tic and OC symptom severity,11 whereas other studies suggest that OC symptoms in TD are associated with increased tic severity.9, 12, 13 With respect to the relationship between depressive and anxiety symptom severity on the one hand and tic severity on the other, Rizzo et al7 compared a group of TD patients with comorbid depression diagnoses with TD patients without comorbid depression and found that tic severity was higher in the TD + Depression group. Further, Marwitz and Pringsheim14 found a positive correlation between depression (r = .37) as well as anxiety severity (r = .22) and tic severity in children. However, the direction of these relationships is unclear: Is there an effect of anxiety or depression on tic severity or vice versa, and if so, are those effects additive or multiplicative? Regarding the relationship between tic symptom severity, OC symptom severity, and/ or depressive and anxiety symptom severity on the one hand, and QoL on the other: Generally, tic and OC symptoms are highly correlated,15 and have been found to be associated with decreased QoL, lower psychosocial functioning, and lower academic achievement.16, 17, 18, 19, 20 Tic severity in children has been found to be a predictor of poor outcome on physical, psychological and cognitive domains of QoL later in life.21 Especially, comorbidity with OC symptoms has shown to be an aggravating factor and leads to decreased global functioning,22 lower self‐esteem and difficulties in relationships23 as well as a negative influence on vitality, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health.12 Presence and severity of anxiety disorders are positively associated with OCD diagnosis and OC symptom severity in TD, although the nature of the association with QoL is subject to debate.4, 7, 9, 24, 25 Research in TD including both anxiety and OC symptom comorbidity has indicated that depression was the main predictor of QoL in TD patients.26 Some researchers argue that increased frequencies of comorbid anxiety and depression symptoms in TD are secondary to disease burden27 and thus negatively impact QoL.11 Others argue that anxiety and depression negatively influence QoL through an increase in other comorbidities like OCD. Finally, a recent literature review by Evans et al28 suggests that QoL profiles in TD children often reflect the negative effect of comorbid OCD and ADHD while in adults QoL is mostly negatively influenced by comorbid depression and anxiety.

Aims of the study

To summarize, in adults with TD, there is a complex relationship between OC, anxiety and depression symptom severity on the one hand and tic severity and QoL on the other. In this study, we aimed to extend previous findings by investigating the structure of the interrelationships, using mediation and moderation analyses. Mediation analyses, although cross‐sectional in nature, hypothesize causal relations and their directions between various contributors and tic severity and QoL, and thus shed light on how these comorbidities interact and reinforce each other in their effect on QoL and tic severity. Based on previous findings, we aimed at exploring whether (a) OC, depression and anxiety severity predict an increase in tic severity; (b) OC symptom severity either interact with or mediate the effect of anxiety and depression severity in an aggravating effect on tic severity; (c) Tic severity, OCD, depression, and anxiety severity have a negative effect on QoL; (d) depression severity and OC symptom severity either interact with or mediate the effect of tic severity and anxiety severity in a negative effect on QoL.

MATERIAL AND METHODS

Participants

Clinical data were obtained from 187 participants with a DSM‐IV‐TR diagnosis of TD (72 females and 115 males, with an average age of 36.61; range: 18‐65). For a thorough description of the study group, see de Haan et al.29 Of these 187 participants, 129 were assessed on psychiatric comorbidity using semi‐structured interviews. A table with the frequencies of (comorbid) mental disorders is provided in the Appendix 1.

Procedure

Participant recruitment was carried out between 2001 and 2008 in the scope of a genetic study on TD that was approved by the Medical/Ethical Review Board of the VU University Medical Center. All study subjects gave written informed consent. Participants were recruited via two Dutch outpatient clinics (GGZ Ingeest and Altrecht Academic Anxiety center) specialized in diagnosing and treatment of TD, and through the Dutch Tourette's syndrome patients' association. Participants with TD were invited for assessment and were sent self‐report questionnaires to fill in. During the assessment a diagnostic interview entailing either the SCID‐I or MINI was carried out by research nurses and psychologists trained in diagnosing TD and other DSM‐IV axis 1 diagnoses (see the measurements section for a description). Participants were reimbursed for travel expenses.

Measurements

Yale Global Tic Severity Scale (YGTSS)

The YGTSS is a semi‐structured clinician‐rated instrument used to assess the characteristics and severity of motor and vocal tics in the week preceding the assessment (Leckman et al30). Global tic severity is established by summing the total scores of the vocal and the motor scale (number, frequency, intensity, complexity, interference with item score ranges between 0 and 5 for the motor and vocal tics separately), without the impairment item, creating a total score (range 0‐50). The YGTSS is a reliable and valid instrument with excellent internal consistency.31, 32 Cronbach's alpha of the YGTSS in the current study was .95; the average score in our sample was 17.81 (SD = 10.11).

Structured Clinical Interview for DSM‐IV Axis I Disorders (SCID‐I)

The SCID‐I is a semi‐structured interview designed to systematically diagnose the most prevalent DSM‐IV Axis I disorders.33 Research has shown excellent reliability for all disorders34, 35 and high validity.36

Mini International Neuropsychiatric Interview (MINI), version 5.0.0

The MINI is a semi‐structured interview to systematically diagnose the most prevalent DSM‐IV axis I disorders.37 Good to very good inter‐rater reliability has been established37; sensitivity and specificity as well as test‐retest reliability for all diagnoses has shown to be good, except for generalized anxiety disorder (GAD; κ = 0.36), agoraphobia (sensitivity = 0.59), and bulimia nervosa (κ = 0.53).37, 38, 39

Beck Anxiety Inventory (BAI)

The BAI is a 21 item self‐report scale designed to measure anxiety severity over the past week.40 Items are rated on a 4‐point scale ranging from 0 (“not at all”) to 3 (“severe”) and are added up to a total score (range 0‐63). Numerous studies have supported the reliability, internal consistency and validity of this instrument.40 In the current study, Cronbach's alpha was .91; the average score in our sample is 9.77 (SD = 9.28).

Beck Depression Inventory‐II (BDI‐II)

The BDI‐II is a self‐report scale containing 21‐items rated on a 4‐point scale, ranging from 0 (“not at all”) to 3 (“severely”).41, 42 All items are added up to a total score (range 0‐63) measuring severity of depressive symptoms over the past week. The internal consistency of the BDI is good to excellent.42 Cronbach's alpha of the BDI in this study was .89; the average score in our sample is 9.64 (SD = 8.22).

Yale‐Brown Obsessive‐Compulsive Scale (Y‐BOCS)

The Y‐BOCS is a 10 item (range 0‐4) semi‐structured interview used to assess the severity of obsessions (five items) and compulsions (five items).43 All items (time, distress, interference, resistance, and control measured separately for obsessions and compulsions) are added up to a total score (range 0‐40). Goodman et al44 found an excellent validity, high inter‐rater reliability and internal consistency. The average score in our sample is 8.82 (SD = 8.90).

Euro Qol‐5D (EQ‐5D)

The EQ‐5D comprises five dimensions measuring QoL: mobility, self‐care, usual activities, pain/discomfort and anxiety/depression.45 Also, it contains a visual analogue scale (the EQ‐VAS) that records the patient's self‐rated health which can be used as a quantitative measure of health outcome according to the patient's own judgement. Convergent validity of the EQ‐5D is moderate to strong and reliability has been found to be good; however, the EQ‐5D seems to be better at detecting large than small changes in physical health.46 Since the population in our study was relatively young with high physical health, the EQ‐5D total score showed insufficient variability for the analyses in our study. Therefore, we decided to primarily use the EQ‐VAS item. The wording of the EQ‐VAS question is: “Please indicate on the line how good or bad your health is today.” The scale ranges from 0 (“worst imaginable health”) to 100 (“best imaginable health”). The EQ‐VAS showed sufficient score variability, with an average score in our sample of 71.62 (SD = 17.99).

Statistical analyses

All analyses were performed using the statistical software SPSS (version 22). A significance level of P ≤ .05 was adopted and two‐tailed analyses were used. First, Pearson correlations were calculated between the BAI, BDI, Y‐BOCS, YGTSS, and EQ‐VAS. Second, stepwise linear regression analyses were used to analyze BAI, BDI, and Y‐BOCS scores as predictors of EQ‐VAS (QoL) and YGTSS (tic severity); all possible two‐way interactions were calculated and added to the model, and R 2 change was evaluated for model selection. In order to evaluate the added value of each of the variables as well as the interactions separately, all variables were entered in the regression one by one according to their correlational strength with the dependent variable. Finally, PROCESS bootstrap mediation analyses were performed to test indirect effects of BAI, BDI, and Y‐BOCS scores on EQ‐VAS and YGTSS. To assess their effect on tic severity and QoL, variables that did not show significant effects in the linear regression were entered as predictors and variables that showed significant direct effects were entered as mediators in the bootstrap analyses.47 The number of bootstraps was set to 50 000 with confidence intervals (CI) of 90%, 95%, and 99%. For the interpretation of the mediation effect the “index of mediation” was used, which is the completely standardized indirect effect. An index of mediation can be interpreted using Cohen's guidelines for squared correlation coefficients which defines a small, medium, and large effect as 0.01, 0.09, and 0.25.48

RESULTS

Correlations

Table 1 shows correlations between anxiety severity (BAI), depression severity (BDI), OC symptom severity (Y‐BOCS), tic severity (YGTSS), and QoL (EQ‐VAS). All correlations between anxiety, depression, OC symptom severity, and QoL were significant, meaning that all comorbid symptoms except tic symptom severity were correlated. Depression, anxiety, and OC symptom severity were all negatively correlated with QoL, with depression severity showing the highest negative correlation with QoL (r = −.626), followed by anxiety severity (r = −.534) and OC symptom severity (r = −.415); tic severity did not correlate with QoL. Regarding relationships with tic severity only OC symptom severity was significantly correlated (r = .191), all other correlations with tic severity were not significant.
Table 1

Pearson correlations between EQ‐VAS, BDI, BAI, Y‐BOCS, and YGTSS

 EQ‐VASBDIBAIY‐BOCSYGTSS
EQ‐VAS1    
BDI−0.626*** 1   
BAI−0.534*** 0.658*** 1  
Y‐BOCS−0.415*** 0.440*** 0.395*** 1 
YGTSS−0.2110.1700.1170.191* 1

P < .05 (2‐tailed).

P < .001 (2 tailed).

Pearson correlations between EQ‐VAS, BDI, BAI, Y‐BOCS, and YGTSS P < .05 (2‐tailed). P < .001 (2 tailed).

Predictors of tic severity

As shown in Table 2, only OC symptom severity was a significant predictor of tic severity with a considerable effect (b = .24, P < .05). Adding depression and anxiety severity did not result in a significant increase in explained variance in tic severity; that is, it did not result in a better model, leaving OC symptom severity as the only predictor of tic severity. To investigate whether OC severity scores interact with depression and anxiety severity, or if depression and anxiety severity combined act as predictors of tic severity, three interaction terms were added to the model (Table 2). However, adding interaction terms to the model did not cause a significant increase in explained variance in tic severity.
Table 2

Results on tic severity

Regression coefficients, β values, and P values for BDI, BAI, and Y‐BOCS, as predictors of YGTSS and R 2 change for added predictors
Predictor YGTSS
B β P
Y‐BOCS .24.20.039
Model R2 Adj R2 R2 change P
1: Y‐BOCS.04.03.04.039
2: BDI added.05.03.01.323
3: BAI added.05.02.00.969
4: BDI*Y‐BOCS added.05.01.00.665
5: BAI*Y‐BOCS added.05.00.00.820
6: BDI*BAI added.08.02.03.100

Coefficient: The change in the dependant variable with the increase of one point in the independent variable, assuming all other variables remain equal.

Abbreviation: NS, not significant.

CI 99%.

P < .05.

P < .001.

Results on tic severity Coefficient: The change in the dependant variable with the increase of one point in the independent variable, assuming all other variables remain equal. Abbreviation: NS, not significant. CI 99%. P < .05. P < .001. In order to test whether OC symptom severity mediates an effect of depression or anxiety severity on tic severity, two bootstrap mediation analyses were performed: a model with OC symptom severity as mediator of the effect of depression severity on tic severity (model 1) and a model with OC symptom severity as a mediator of the effect of anxiety severity on tic severity (model 2; see Table 2). In model 1, there was no indirect mediation effect of depression severity on tic severity through OC symptom severity. Interestingly, in model 2, there was a significant mediation effect of anxiety severity on tic severity through OC symptom severity, indicating that anxiety severity has a negative influence on tic severity through the negative effect on OC symptom severity (see Figure 1 for a graphical representation of this indirect effect). With an index of mediation of 0.06 this was only a small effect.
Figure 1

Graphic representation of the indirect effects of anxiety, OC symptom, and depression severity on tic severity. +, Positive effect

Graphic representation of the indirect effects of anxiety, OC symptom, and depression severity on tic severity. +, Positive effect

Predictors of QoL

As shown in Table 3 only depression severity significantly predicted QoL, with a considerable negative effect (b = −1.19, P  <.001). Adding anxiety, OC symptom severity and tic severity to the model did not result in a significant improvement of the amount of variance explained by the model, leaving depression severity to be the only predictor of QoL. Adding interaction terms to the model did not yield a significant improvement of the model.
Table 3

Results on QoL

Regression coefficients, β values, and P values for BDI, BAI, Y‐BOCS, YGTSS, as predictors of EQ‐VAS and R 2 change values for added interaction
Predictor EQ‐VAS
B β P
BDI −1.19−.59.000
Model R2 Adj R2 R2 change P
1: BDI.34.33.34.000
2: BAI added.37.35.03.131
3: Y‐BOCS added.38.34.01.543
4: YGTSS added.38.33.00.975
5: BDI*Y‐BOCS added.38.31.00.883
6: BAI*Y‐BOCS added.42.35.04.052
7: BDI*YGTSS added.46.38.04.104

Coefficient: The change in the dependant variable with the increase of one point in the independent variable, assuming all other variables remain equal.

Abbreviation: NS, not significant.

CI 99%.

P < .05.

P < .001.

Results on QoL Coefficient: The change in the dependant variable with the increase of one point in the independent variable, assuming all other variables remain equal. Abbreviation: NS, not significant. CI 99%. P < .05. P < .001. Table 3 shows the results of the bootstrap analyses with depression severity as a mediator of the effect of, respectively, OC symptom severity (model 1); anxiety severity (model 2); and tic severity (model 3) on QoL. Results indicate an effect of OC symptom severity (model 1), as well as anxiety severity (model 2) on QoL with depression severity as a mediator. The index of mediation of both effects is large with 0.32 for model 1 and 0.33 for model 2. Results showed no indirect effect of tic severity on QoL (see Figure 2 for a graphical representation of the indirect effects).
Figure 2

Graphic representation of the direct and indirect effects of anxiety, OC symptoms, and depression symptoms on QoL. +, Positive effect; −, Negative effect

Graphic representation of the direct and indirect effects of anxiety, OC symptoms, and depression symptoms on QoL. +, Positive effect; −, Negative effect

DISCUSSION

In this study, the effects of OC, anxiety, and depression severity on tic severity and QoL in TD patients were investigated. This study is the first to use mediation analyses to study the combination of predictors of QoL and tic severity in concert. In contrast to our expectations results indicate that only OC symptom severity significantly predicted tic severity. Further, OC symptoms did not interact with depression and anxiety severity, nor did they mediate the effect of depression severity on tic severity. This refines the specific role of anxiety and depression severity in TD patients and highlights the importance of OC symptoms in TD. There is a wealth of research that shows that anxiety and depression aggravate tic severity.11, 24 Our results nuance these findings by showing that this is not the result of a direct effect of anxiety or depression severity on tic severity. However, in line with our expectations we did find a small mediation effect of anxiety severity on tic severity through OC symptom severity, indicating that the more severe anxiety symptoms are, the higher the increase in OC symptom severity, resulting in higher tic severity. We did not find a direct or indirect effect of depression severity on tic severity, nor was depression symptom severity associated with tic severity. We did find a strong correlation between depression severity and OC symptom severity, but an increase in depression severity did not result in an increase of the effect of OC symptom severity on tic severity. These findings strongly suggest that depression is more likely to be the result rather than a cause of OC symptom severity, a conclusion that should be confirmed in further studies using longitudinal data. One 2 year prospective study with between 4 and 24 measurements has specifically addressed this issue: In 45 cases (age 7‐17 years) with either TD, TD + OCD, or OCD, and in 41 matched controls, the temporal relationship between psychosocial stress and severity of tics, OC and depressive symptoms were studied. In line with the current study, OC symptom severity at baseline predicted future depressive symptoms. Further, and importantly, depression at baseline was an independent predictor of future tic symptom severity. Reversely, tic severity only very modestly predicted future depression. Thus, depressive symptoms in children and adolescents seem to be markers of later tic severity, rather than tic severity predisposing to later depressive symptoms.49 In our study, the role of depression symptoms on QoL in TD was profound, showing that depression severity was a mediator of the effect of both anxiety and of OC symptom severity on QoL. This again suggests that depression in TD is a result of OC symptom and anxiety symptom disease burden, but not of tic severity. In contrast to our expectations, depression severity rather than anxiety and OC symptom severity directly influenced QoL. However, depression severity was predicted by OC and anxiety severity and thus was a mediator in the effect on QoL. In other words, anxiety and OC symptom severity seem to result in a decrease in QoL by exacerbating depressive symptoms. These findings supplement previous findings5, 7, 9 which showed that comorbid OCD was related to higher scores of depression and anxiety in patients with TD, and that in TD QoL was mostly influenced by comorbid depression and anxiety symptom severity.28 We did not find any direct or indirect effect of tic symptom severity on QoL. In line with this, Coffey et al50 examined 156 young TD patients (between 5 and 20 years) on whether they needed hospitalization (as a proxy of disease severity). Of the 19 (12%) TD patients who required psychiatric hospitalization, major depression, bipolar disorder, panic disorder, and overanxious disorder were significant predictors of hospitalization, whereas tic severity only marginally predicted hospitalization. However, results of more recent studies suggest the opposite: Eddy et al23 found impaired self‐esteem and relations including lower QoL in young TD patients without comorbidity. A difference with our study is that Eddy et al defined “pure” cases as opposed to comorbid cases based on presence or absence of categorical comorbid diagnoses. As a result, TD cases with subtle or subthreshold OC, anxiety and/ or depressive symptoms below the threshold of a full comorbid diagnosis may well have been included in their group of “pure” TD cases, with the subthreshold comorbidities resulting in lowered QoL. Another possible explanation of these apparent divergent results is that we examined adults, whereas Eddy et al examined children and adolescents. Especially, the adolescents may have been more prone to age‐related insecurities as a result of tics than the adults of our sample. Further, our results are partly in contrast with Elstner et al11 who found significantly lower QoL in TD patients as compared to the general population. Apparently, there are qualitative differences in QoL between adults with persistent TD and healthy comparison subjects, with our study taking a different angle by investigating the effect of tic severity as a continuous predictor of QoL in a group of TD patients. However, in line with our findings, when comparing TD patients with high OC severity and depression scores versus low OC and depression severity scores they found that patients with high OC and depression severity had lower QoL scores. This highlights the importance of investigating comorbidities in TD in concert to unravel their combined effect on QoL. The results of this study suggest that several mediators differentially form a network of anxiety, depression, and OC symptom severity influencing QoL in TD. Figure 3 shows what this network could look like. OC symptom severity seems to be crucial for the final outcomes on both tic severity and QoL. However, this full model cannot be tested using only mediation analyses but needs to be estimated using other statistical approaches, like structural equation modeling or network analyses. Our results merely show the structure of the mutual effects of the comorbidities, tic severity and QoL. Even though our results may reflect causal relations, extension of cross‐sectional data to a longitudinal data approach is warranted to establish causal relationships. Prospective longitudinal studies can shed more light on the direction of the relationship between tic severity, anxiety, and depression.
Figure 3

Graphic representation of a potential model combining the results of our study. +, Positive effect; −, Negative effect

Graphic representation of a potential model combining the results of our study. +, Positive effect; −, Negative effect

Limitations

Our study has several limitations. First, for the assessment of anxiety and depression symptom severity and QoL, only self‐report instruments were used. Further, the data of this study are cross‐sectional, and therefore directions of predictive effects are estimated in regression models, and may not necessarily reflect causality. Also, our study did not include a disorder‐specific QoL measurement, and therefore may be unable to detect subtle and disorder related domains of QoL. And lastly this study did not take into account ADHD symptoms, although ADHD represents an important source of comorbidity both in children and adults, and earlier studies have reported ADHD symptoms to influence tic severity and QoL.6, 7, 18, 23

Implications for clinical practice and suggestions for future research

Our findings are of great importance for treatment of adult TD patients when it comes to improving QoL. Since tic severity was not predictive of QoL and has been only marginally predictive in other studies, treatment should focus predominantly on OC symptoms and depression, rather than on tic reduction; especially reduction of OC symptoms might be more important in contributing to decrease of tic severity than direct tic treatments, although this important issue has not been investigated in direct comparative prospective studies. Regarding the high percentage of comorbidities in clinical patients with TD, our results show that instead of focusing on diagnostic boundaries of disorders, much more attention should be given to the dynamics between symptoms across disorders. Furthermore, future studies should include ADHD symptoms in modeling their relationship with QoL in TD patients. Finally, in order to test causal relationships between symptoms, longitudinal studies in sufficiently large samples are needed. To conclude, this study extends previous research and provides potential explanations for previous inconsistencies in the literature on the effects of OC symptom severity, anxiety, and depression severity on tic severity and QoL. Investigating the mutual relationships of the various comorbid symptoms in TD has provided more insight in the complex and crucial role of OC symptom severity on longer term TD outcome.

CONFLICT OF INTEREST

The authors declare no conflicts of interest.
DisordersFrequencies of mental disorders
TD participants
CurrentPast
n (%)n (%)
Anxiety disorder75 (50)7 (4)
OCD57 (38)
PTSD5 (3)
GAD25 (17)
Social phobia21 (14)
Panic disorder  
With agoraphobia5 (3)2 (1)
Without agoraphobia8 (5)5 (3)
Agoraphobia
Hypochondria2 (1)
Specific phobiaa 16 (11)
Mood disorder37 (25)32 (21)
Depression27 (18)30 (20)
Depression with melancholic features5 (3)
Dysthymia7 (5)
Bipolar 11 (<1)
Bipolar 21 (<1)
Hypomania episode2 (1)
Manic
Dependency and abuse19 (13)12 (8)
Substance abuse and dependency19 (13)10 (7)
Abuse8 (5)4 (3)
Alcohol6 (4)3 (2)
Drugs2 (1)2 (1)
Dependency14 (9)8 (5)
Alcohol9 (6)3 (2)
Drugs6 (4)7 (5)
Drug induced disorders3 (2)
Eating disorders4 (3)1 (<1)
Anorexia nervosa1 (<1)1 (<1)
Bulimia nervosa1 (<1)1 (<1)
Binge eating disorder2 (1)
Other disorders6 (4)2 (1)
Psychotic disorders1 (<1)
Psychotic disorder NAO1 (<1)1 (<1)
Cyclothymia1 (<1)
Undifferentiated Somatoform disorder
Pain disorder1 (<1)
Impulse control disordersa 2 (1)1 (<1)

Diagnoses were only assessed in the SCID but not in the MINI.

  46 in total

1.  Tic-related school problems: impact on functioning, accommodations, and interventions.

Authors:  Leslie E Packer
Journal:  Behav Modif       Date:  2005-11

2.  Quality of Life (QOL) of patients with Gilles de la Tourette's syndrome.

Authors:  K Elstner; C E Selai; M R Trimble; M M Robertson
Journal:  Acta Psychiatr Scand       Date:  2001-01       Impact factor: 6.392

3.  Internal consistencies of the original and revised Beck Depression Inventory.

Authors:  A T Beck; R A Steer
Journal:  J Clin Psychol       Date:  1984-11

4.  Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II).

Authors:  Jill Lobbestael; Maartje Leurgans; Arnoud Arntz
Journal:  Clin Psychol Psychother       Date:  2011 Jan-Feb

5.  The impact of tics, obsessive-compulsive symptoms, and impulsivity on global functioning in Tourette syndrome.

Authors:  Yukiko Kano; Toshiaki Kono; Natsumi Matsuda; Maiko Nonaka; Hitoshi Kuwabara; Takafumi Shimada; Kurie Shishikura; Chizue Konno; Masataka Ohta
Journal:  Psychiatry Res       Date:  2015-01-07       Impact factor: 3.222

Review 6.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

7.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

8.  Tourette syndrome and comorbid conditions: a spectrum of different severities and complexities.

Authors:  Renata Rizzo; Mariangela Gulisano; Alessandra Pellico; Paola Valeria Calì; Paolo Curatolo
Journal:  J Child Neurol       Date:  2014-05-14       Impact factor: 1.987

Review 9.  The psychopathological spectrum of Gilles de la Tourette syndrome.

Authors:  Andrea E Cavanna; Hugh Rickards
Journal:  Neurosci Biobehav Rev       Date:  2012-11-03       Impact factor: 8.989

10.  New Insights into Clinical Characteristics of Gilles de la Tourette Syndrome: Findings in 1032 Patients from a Single German Center.

Authors:  Tanvi Sambrani; Ewgeni Jakubovski; Kirsten R Müller-Vahl
Journal:  Front Neurosci       Date:  2016-09-12       Impact factor: 4.677

View more
  7 in total

Review 1.  The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future.

Authors:  Davide Martino; Wissam Deeb; Joohi Jimenez-Shahed; Irene Malaty; Tamara M Pringsheim; Alfonso Fasano; Christos Ganos; Winifred Wu; Michael S Okun
Journal:  Neurology       Date:  2021-02-16       Impact factor: 9.910

2.  Lifetime Prevalence, Predictors and Comorbidities of Tic Disorders: A Population-Based Survey of Children and Adolescents in Iran.

Authors:  Mohammad Reza Mohammadi; Rahim Badrfam; Ali Khaleghi; Nastaran Ahmadi; Zahra Hooshyari; Atefeh Zandifar
Journal:  Child Psychiatry Hum Dev       Date:  2021-05-09

3.  Tic disorders in children and adolescents: does the clinical presentation differ in males and females? A report by the EMTICS group.

Authors:  Andrea Dietrich; Astrid Morer; Blanca Garcia-Delgar; Mateu Servera; Barbara J Coffey; Luisa Lázaro; Thaïra Openneer; Noa Benaroya-Milshtein; Tami Steinberg; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-05-04       Impact factor: 5.349

4.  Clinical Correlates of Health-Related Quality of Life in Adults With Chronic Tic Disorder.

Authors:  David A Isaacs; Heather R Riordan; Daniel O Claassen
Journal:  Front Psychiatry       Date:  2021-03-10       Impact factor: 4.157

5.  Cross-cultural adaptation and psychometric evaluation of the French version of the Gilles de la Tourette Syndrome Quality of Life Scale (GTS-QOL).

Authors:  Isabelle Jalenques; Diane Cyrille; Philippe Derost; Andreas Hartmann; Sophie Lauron; Clara Jameux; Urbain Tauveron-Jalenques; Candy Guiguet-Auclair; Fabien Rondepierre
Journal:  PLoS One       Date:  2020-12-22       Impact factor: 3.240

Review 6.  European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment.

Authors:  Kirsten R Müller-Vahl; Danielle C Cath; Natalia Szejko; Sally Robinson; Andreas Hartmann; Christos Ganos; Nanette M Debes; Liselotte Skov; Martina Haas; Renata Rizzo; Jeremy Stern; Alexander Münchau; Virginie Czernecki; Andrea Dietrich; Tara L Murphy; Davide Martino; Zsanett Tarnok; Tammy Hedderly
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-10-18       Impact factor: 4.785

7.  Implementation of the Mini-Child Tourette Syndrome Impairment Scale: Relationships to Symptom Severity and Treatment Decisions.

Authors:  Jordan F Garris; David A Huddleston; Hannah S Jackson; Paul S Horn; Donald L Gilbert
Journal:  J Child Neurol       Date:  2020-10-30       Impact factor: 1.987

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.